PFE - Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts | Benzinga
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024.
Analysts expect the company to report a quarterly loss at 22 cents per share, versus year-ago earnings of $1.14 per share. The company is projected to post revenue of $14.43 billion for the latest quarter, compared to $24.29 billion in the year-earlier quarter, according to data from Benzinga Pro.
Daiichi Sankyo Co Ltd recently announced that the U.S. Patent and Trademark Office rendered a Final Written Decision invalidating all claims of Seagen Inc's U.S. patent 10,808,039 challenged by Daiichi Sankyo in a post-grant review proceeding, related to a cancer drug.
In ...